A European Perspective on High-Impact Data From ASH 2019*

December 7-10, 2019; Orlando, Florida
Review slidesets and expert commentaries on key findings from ASH 2019, tailored for European clinicians.
person default
Michael Heuser, MD
Jesús F. San-Miguel, MD, PhD
Lydia Scarfò, MD

Acute and Chronic Leukemias

Download this summary slideset with highlights of key data in acute and chronic leukemias from ASH 2019.

Released: December 23, 2019

Michael Heuser, MD, provides his thoughts on key studies in leukemias presented at ASH 2019 and their potential implications for practice in Europe.

person default Michael Heuser, MD Released: January 24, 2020

Lymphomas and Chronic Lymphocytic Leukemia

Download this summary slideset with highlights of key data in chronic lymphocytic leukemia and lymphomas from ASH 2019.

Released: December 23, 2019

In this commentary, Lydia Scarfò, MD, provides a European perspective on 5 key studies in CLL and lymphomas presented at ASH 2019.

Lydia Scarfò, MD Released: January 28, 2020

Multiple Myeloma

Download this summary slideset with highlights of key data in multiple myeloma from ASH 2019.

Released: December 23, 2019

In this commentary, Jesús F. San-Miguel, MD, PhD, provides his perspective on key studies from ASH 2019.

Jesús F. San-Miguel, MD, PhD Released: January 28, 2020
Supported by educational grants from
AbbVie
AstraZeneca
Gilead Sciences
Jazz Pharmaceuticals, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue